In this regard, a specific effect of the JMJD3 inhibitor GSK-J4 in preventing ITGB3 and ITGB4 upregulation upon combined treatment was observed in PCa cells (Figure 7a). This evidence concerns the gene KDM6B and posterior cortical atrophy.